Indian J Hum Genet. 2010 Sep;16(3):133-7. doi: 10.4103/0971-6866.73403.
The NQO1 allelic frequency in hindu population of central India varies from that of other Asian populations.
Indian journal of human genetics
Sher S Parihar, U K Chauhan
Affiliations
Affiliations
- School of Environmental Biology, Awdhesh Pratap Singh University, Rewa 486 003, Madhya Pradesh, India.
PMID: 21206700
PMCID: PMC3009423 DOI: 10.4103/0971-6866.73403
Abstract
CONTEXT: THE ENZYMES ENCODED BY THE POLYMORPHIC GENES NAD (P) H: quinone oxidoreductase 1 (NQO1) play an important role in the activation and inactivation of xenobiotics. This enzyme has been associated with xenobiotic related diseases, such as cancer, therapeutic failure and abnormal effects of drugs.
AIM: The aim of the present study was to determine the allelic and genotypic frequencies of NQO Hinf I polymorphisms in a Hindu population of Central India.
SETTINGS AND DESIGN: Polymorphisms of NQO1 were determined in 311 unrelated Hindu individuals.
MATERIALS AND METHODS: Polymerase chain reaction- Restriction Fragment Length Polymorphism (PCR-RFLP) analysis in peripheral blood DNA for NQO1 Hinf I polymorphism was used in 311 unrelated Hindu individuals.
STATISTICAL ANALYSIS: Allele frequencies were calculated by direct counting. Hardy Weinberg Equilibrium was evaluated using a Chi-square goodness of fit test.
RESULTS: The observed allelic frequency was 81% for C (wild) and 19% for T (mutant) in the total sample.
CONCLUSIONS: The allelic frequency of "C" was higher than in other Asians (57%), but similar to Caucasians (81%). The genotype distributions for Hinf I polymorphisms were in Hardy-Weinberg equilibrium.
Keywords: Cancer; NQO1; polymorphism
References
- Pharmacogenetics. 2003 Jun;13(6):349-55 - PubMed
- Free Radic Biol Med. 2000 Aug;29(3-4):231-40 - PubMed
- Nucleic Acids Res. 1988 Feb 11;16(3):1215 - PubMed
- Cancer Epidemiol Biomarkers Prev. 1997 Feb;6(2):87-92 - PubMed
- Br J Cancer. 1996 Sep;74(6):995-6 - PubMed
- J Nephrol. 2004 May-Jun;17(3):384-9 - PubMed
- Free Radic Biol Med. 2000 Aug;29(3-4):254-62 - PubMed
- J Korean Med Sci. 2006 Dec;21(6):1075-9 - PubMed
- Methods Enzymol. 1990;186:287-301 - PubMed
- Cancer Epidemiol Biomarkers Prev. 2004 Jun;13(6):908-14 - PubMed
- Cancer Epidemiol Biomarkers Prev. 2003 Dec;12(12):1536-9 - PubMed
- Br J Cancer. 1997;76(7):852-4 - PubMed
- Cancer Res. 1999 Jul 1;59(13):3045-8 - PubMed
- Proc Natl Acad Sci U S A. 2002 Mar 5;99(5):3099-104 - PubMed
- Chemosphere. 2008 Feb;70(10):1835-9 - PubMed
- Carcinogenesis. 2003 May;24(5):905-9 - PubMed
- Cancer Epidemiol Biomarkers Prev. 2006 Dec;15(12):2422-6 - PubMed
- Biochemistry. 1991 Nov 5;30(44):10647-53 - PubMed
- Br J Cancer. 1997;75(1):69-75 - PubMed
- Proc Natl Acad Sci U S A. 1999 Jul 6;96(14):7624-6 - PubMed
- Cancer Epidemiol Biomarkers Prev. 2004 Aug;13(8):1308-15 - PubMed
- Genet Med. 2005 Sep;7(7):463-78 - PubMed
Publication Types